AMY SCHAFER: Open Payments
NPI 1013566132 · LAWRENCEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 28 payments from 7 companies in 2025. Trend: 2023 $143 · 2024 $347 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $125 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Corium, LLC | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: Qelbree, INGREZZA, Azstarys, CAPLYTA, FANAPT, Jornay PM, Auvelity.
Industry payments across IL — which companies pay providers there.
